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INTRODUCTION     
In oral cavity, mandibular third molar is one of the 
commonly impacted tooth.1 There are various 
reasons for impaction of a tooth but the lack or loss 
of space in the arch is the major cause.2 It can be due 
to combination of genetic and environmental factors 
resulted in discrepancy in size of tooth and jaw. In 
most of the cases, impacted mandibular molar are 
asymptomatic but pathology can develop in some 
cases. The problems associate with molars can be 
from simple dental caries to more complex 
conditions such as formation of cyst or development 
of malignant lesion in the follicular tissue 
surrounded by the tooth.3 Therefore extraction of 
impacted third molars is necessary and it is the most 
common practice in speciality of oral surgery so that 
prevent the suspected pathology before its arousal.4 
Surgical extraction of third molar irrespective of any 
technique results in postoperative pain, swelling of 
face and limited mouth opening.5 There are various 
measures to alleviate the pain, swelling and trismus 
which includes application of cold or heat, oral or 
intravenous non-steroidal anti inflammatory agents 
(NSAIDs), corticosteroids.6 
 
Many researchers suggested use of local injection of  
 
 
 
steroid to overcome post-operative inflammation of  
surrounding tissue.7-9 However, use of local or 
systemic steroid have some side-effects such as risk 
of infection, hyperglycemia and suppression of 
immune system.10 Surgical extraction of impacted 
molar associates with injury to surrounding soft and 
bony tissues and may result in pain, swelling and 
trismus. These symptoms commonly arise after two 
days of extraction.11 The sequel after surgery may 
hamper the patient’s quality of life.  
 
Synthetic corticosteroid, dexamethsone has good 
anti-inflammatory action. Its potency is 20-30 times 
when compared to natural corticosteroid. Alexander 
and Throndson observed use of many combination 
of Dexamethasone based on past literature.12  
 
For many years, oral surgeons administered 
intravenous corticosteroids preoperatively or just 
after extraction of third molar in order to decrease 
inflammation and other associated symptoms of 
surgery. Various studies have suggested use of 
NSAIDs drugs is effective for controlling swelling 
and trismus.13,14 The aim of the present study was to 
assess and compare the effects Dexamethasone (4 
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mg) administered prior to surgical third molar 
surgery. 
 
MATERIALS AND METHOD 
A randomized control trial was conducted which 
included a total of fifty patients who reported to the 
Department of Oral and Maxillofacial Surgery in a 
Dental College & Hospital, Jaipur, Rajasthan. 
 
Inclusion criteria 
 Patients were 15 to 40 years of age.  
 Patients without any significant medical 
history. 
 All patients who have impacted lower third 
molars undergoing transalveolar extraction of 
the impacted third molar. 
 
Exclusion Criteria 
 Medically compromised patients  
 Pregnant and lactating women were excluded 
 Patient who had periapical pathology in the 
tooth to be extracted 
 Patients who had habit of Smoking and 
consuming alcohol 
 Uncooperative patients  
 
Fifty patients who fulfilled the above criteria were 
included for the study. Informed written consent 
was taken from patients after explaining the about 
the procedure and follow up of the study. Intraoral 
periapical (IOPA) radiograph and 
Orthopantamogram was taken for all the subjects. 
Routine blood investigations were carried out. 
Detail history of patients was taken to rule out use 
of preoperative antimicrobial, NSAIDs or other 
drugs that might influence healing and 
inflammation. All the patients were randomly put in 
two groups of twenty five each. 
 
Group I patients underwent transalveolar extraction 
of third molar under local anesthesia and standard 
oral drug regime. Group II patients received an 
additional submucosal injection of dexamethasone 4 
mg, thirty minutes prior administration of local 
anaesthesia. All patients were operated by the single 
oral surgeon and the surgical wound was closed with 
3-0 silk suture.  
 
Patients were instructed to rinse their mouth with 
5% betadine solution for one minute. An inferior 
alveolar nerve block, lingual never block and a long 
buccal nerve block, using 2% lignocaine 
hydrochloride with vasoconstrictor [1:200000] was 
administered. Trapezoid flap was made using a full-
thickness incision. Periosteal elevator was used to 
lift the flap. The surrounding bone was trimmed and 
the tooth was sectioned wherever required by using 
burs and the impacted third molar was extracted 
with the help of forceps and elevators. Patients were 
examined for the symptoms pain, swelling and 
trismus, preoperatively and on the second, seventh, 
tenth postoperative days.  
 
Criteria of assessment 
 Pain: According to visual analogue scale (VAS), all 
the patients was given a 10 cm VAS scale and 
instructed about the rating. They were asked to 
enter their level of pain at the time when analgesic 
is used, and the number of tablets taken till the end 
of the first week of extraction.  
 Swelling: Facial swelling was evaluated by 
measuring the distance from the tragus of ear to 
corner of mouth and to pogonion. Second point was 
measured from ala of nose to the angle of the 
mandible. 
 Trismus: For mouth opening, the subjects were 
asked to open the mouth slowly until the felling of 
first pain. At that point, the distance between the 
incisal edge of the mandibular and maxillary 
anterior teeth was measured using a measuring tape.  
The data were collected on printed forms and 
transports into Microsoft excel worksheet and data 
analyzed using SPSS (ver 20.0) statistical package. 
“P” value was set less than or equals to 0.05 as 
statistically significant. 
 
RESULTS 
The group I consisted of 13 (52%) males and 11 (48%) 
females. The patients were from 19-35 years of age. 
The group II consisted of 15 (56%) males and 10 
(44%) females. The patients were from 17 to 35 year 
of age. In the present study it was observed that 33%, 
11% and 49% of the teeth were mesioangular, 
horizontal and distoangular respectively and all 
teeth were moderately difficult.  
 
The measurements of the facial swelling in terms of 
horizontal and vertical components showed no 
statistically significant difference between the 
Group I and Group II. In both Group I and II, 
horizontal and vertical component of the facial 
swelling reached to peak on 2nd postoperative day 
and got nearly normal on 10th day. However there 
was no statistically significant difference between  
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the two groups on any postoperative days. (Table  1 
& 2). Pain and swelling scores were recorded on  
second, seventh and tenth post-operative days after 
surgery. The pain was evaluated using VAS scale   on 
 
 
 Group N Mean Std. 
deviation 
t P value 
HR Pre-op I 25 11.02 0.726 -2.358 0.02* 
II 25 11.36 0.706 
HR 2nd day I 25 11.77 0.765 -0.289 0.773# 
II 25 11.72 0.687 
HR 7th day I 25 11.40 0.758 -0.526 0.600# 
II 25 11.48 0.683 
HR 10th day I 25 11.17 0.707 -1.333 0.186# 
II 25 11.36 0.702 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
the    second,   seventh   and    tenth    post-
operative day. The difference in pain scores on 
second post-operative day between two group 
were found statistically non-significant, however, 
there were significant reduction in pain scores on 
seventh and tenth day in both groups. None of the 
patient in either of the group needed rescue 
NSAIDs or opioid analgesics during the post-
operative period. There was statistically 
significant difference in the severity of pain 
between the two groups. The p value was <0.001 
on each postoperative day. Maximum pain was  
observed on second postoperative day. No 
significant difference was observed between the 
groups with respect to decrease pain by the time. 
Intensity of pain was greater in group I patient on 
all postoperative day. (Table 3) 
 
 
Mouth opening showed statistically significant 
difference between the two groups. The p value on 
each postoperative day was <0.001. In both the 
groups, the results showed reduced mouth 
opening  on  the second  postoperative day with a  
 
 Group N Mean Std. 
deviation 
t P value 
VR Pre-op I 25 9.89 0.658 -2.588 0.011* 
II 25 10.23 0.646 
VR 2nd day I 25 10.56 0.684 0.302 0.763# 
II 25 10.52 0.637 
VR 7th day I 25 10.19 0.725 -1.161 0.248# 
II 25 10.35 0.631 
VR 10th day I 25 9.95 0.636 -1.355 0.179# 
II 25 10.25 0.674 
Table 1. Horizontal measurement of face 
Table 2. Vertical measurement of face 
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mean value of 9.56+0.684 mm in first group and  
09.52 ± 0.637 mm in second group and a gradual  
 
increase in mouth opening thereafter. The Group 
I  got  normal  mouth opening on  7th day whereas  
 
 Group N Mean Std. dev. t P value 
Pain 2nd day I 25 5.84 0.817 12.10 0.061# 
II 25 3.60 1.049 
Pain 7th day I 25 3.02 0.958 8.45 <0.001** 
II 25 1.30 1.073 
Pain 10th day I 25 1.12 1.023 5.33 <0.001** 
II 25 0.22 0.615 
 
 
 
 Group N Mean Std. dev. T P value 
Mmo Pre-op I 25 9.89 0.658 -2.418 <0.001** 
II 25 10.23 0.646 
Mmo VR 2nd day I 25 9.56 0.684 0.302 <0.001** 
II 25 9.52 0.637 
Mmo VR 7th day I 25 10.09 0.725 -1.161 <0.001** 
II 25 10.35 0.631 
Mmo 10thday I 25 10.05 0.636 -1.355 <0.001** 
II 25 10.30 0.637 
 
 
 
 
Group II achieved on 10th day. (Table 4). No 
systemic or local complications were observed 
with preoperative dexamethasone injection in any 
of the patient. Risk of local infection, alveolar 
osteitis was not observed in group II as compared 
to group I. Healing process was traced by long 
term follow ups of the both groups and observed 
no statistically significant change between the 
groups. 
 
DISCUSSION 
Non Steroidal Anti-Inflammatory Drugs are the 
oldest and most widely used drugs in history of 
extraction of teeth. However, no single NSAIDs is 
universally effective or tolerated.15 Need for better 
pain relief measure is of paramount importance 
for the clinician as well as the patient as pain 
during or after treatment can cause serious 
consequences including physiological 
complications, psychological impairments and 
overall affect the quality of life. 
 
Dexamethasone is a most potent, highly selective, 
long acting synthetic corticosteroid which has an 
anti-inflammatory action.13 It has been used by 
oral surgeons since 1965 in an attempt to reduce 
pain and swelling following surgery. Messer and 
Keller used patients as their own controls and 
concluded that thirty percent reduction in pain in 
the Dexamethasone group when assessed 48 hours 
post-operatively. Direct application of the steroid 
in the traumatized tissues may thus reduce the 
inflammation related events.16 
 
Studies by Hooley JR et al.17 and Skjelbred P et al.13 
showed that pain was significantly reduced due to 
use of prophylactic steroid administration. Also, 
Dexamethasone in particular appears to diminish 
pain after surgery.18 
  
Use of corticosteroids to limit postoperative 
edema due to their suppressive action on 
transudation is a well known argument made by 
many authors but few have suggested definitive 
recommendations supported by randomised 
clinical trials.12  
 
A study conducted by Baxendale BR et al. on 
Dexamethasone for reduction of swelling 
following extraction of third molar teeth 
concluded that,  Dexamethasone group had more 
patients with mild swelling and  very few  patients  
Table 3. Measurement of Pain score using Visual Analogue Scale 
Table 4. Maximum Mouth Opening [**Highly Significant (p<0.001)] 
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with severe swelling.19  
 
Another study was conducted by Elhag M et al. for 
establishing anti-inflammatory effects of 
Dexamethasone.20 It was observed that 
Dexamethasone group had mean swelling 
volumes significantly lesser (P<0.05) than their 
controls but at such high dose of 10 mg, incidence 
of hypothalamic-pituitary-adrenal axis 
suppression was increased, as demonstrated by 
marked reduction in plasma cortisol in 
Dexamethasone group. Using the patients as their 
own controls, Messer and Keller concluded that 
there is a considerable reduction in swelling in 
Dexamethasone group in comparison with 
patients who did not administered 
Dexamethasone.16 
 
Graziani F et al. reported that Dexamethasone 
significantly decrease facial swelling especially on 
second post-operative day when maximum facial 
swelling is expected. Also with increase in dosage 
from 4 mg to 10 mg of Dexamethasone, a greater 
reduction in swelling was observed.21 
 
The facial size should reach the pre-operative 
facial measurement by seventh day, nine percent 
increment from the pre-operative measurement 
was observed. This was in agreement with various 
studies conducted by Bamgbose B O et al.22, 
Baxendale B R et al.19, Graziani F et al.21 and Anne 
Pedersen23 but contrary to the above mentioned 
studies and the present study, Neupert EA et al.24 
and Edilby GI et al.25 found that there was no 
significant reduction in swelling between 
Dexamethasone and control groups. 
 
CONCLUSION 
The study finding indicates the efficacy and safety 
of submucosal administration of dexamethasone 
injection during third molar extraction to 
eliminate or reduce post operative pain, swelling 
and trismus. The observations of the present study 
provide a fundamental basis for the use of 
corticosteroids such as dexamethasone sodium 
phosphate in the form of submucosal 
administration in lower than usual doses to 
decrease postoperative inflammation when 
compare to other routes of drug administration. 
Administration of low dose Dexamethasone 
around the extraction site has a more desirable 
effect due to more drug concentration at the site 
of injury for a long time without loss due to 
distribution in system. Moreover, when surgical 
removal of the third molar is done under local 
anesthesia, it is very convenient for both patient 
and oral surgeon to use the submucosal site for 
effective administration of drug. Group 
randomisation, single examiner, regular follow-up 
to achieve the objectives of the study is the 
advantages but minimum sample size and lack of 
blinding procedure are some of the limitation of 
the study. In future, role of other corticosteroids 
such as methyl prednisolone, application of local 
drug delivery methods, optimum dose of steroid, 
histological & radiographic comparison of the 
wound healing can be done.  
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